327 related articles for article (PubMed ID: 34149710)
1. CD3
Mohd Shukri ND; Farah Izati A; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():675250. PubMed ID: 34149710
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
3. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
4. Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus.
Song LJ; Wang X; Wang XP; Li D; Ding F; Liu HX; Yu X; Li XF; Shu Q
Diagn Pathol; 2015 Jun; 10():71. PubMed ID: 26076826
[TBL] [Abstract][Full Text] [Related]
5. Increased IL-23R
Izati AF; Mohd Shukri ND; Wan Ghazali WS; Che Hussin CM; Wong KK
Front Immunol; 2021; 12():690908. PubMed ID: 34484186
[TBL] [Abstract][Full Text] [Related]
6. Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus.
Yang XY; Wang HY; Zhao XY; Wang LJ; Lv QH; Wang QQ
J Clin Immunol; 2013 May; 33(4):767-74. PubMed ID: 23435610
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
8. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and clustering analysis of peripheral blood lymphocyte subsets in children with systemic lupus erythematosus complicated with clinical infection.
Deng Y; Ou YY; Mo CJ; Huang L; Qin X
Clin Rheumatol; 2023 Dec; 42(12):3299-3309. PubMed ID: 37537315
[TBL] [Abstract][Full Text] [Related]
10. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
11. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
Lin J; Yu Y; Ma J; Ren C; Chen W
Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
13. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
Li WX; Pan HF; Hu JL; Wang CZ; Zhang N; Li J; Li XP; Xu JH; Ye DQ
Clin Rheumatol; 2010 Mar; 29(3):315-23. PubMed ID: 20012119
[TBL] [Abstract][Full Text] [Related]
14. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
15. Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes.
Piantoni S; Regola F; Zanola A; Andreoli L; Dall'Ara F; Tincani A; Airo' P
Lupus; 2018 Jan; 27(1):143-149. PubMed ID: 28764616
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
17. The role of T helper cell subsets in pathogenesis of Systemic Lupus Erythematosus and their relation to disease activity.
Al-Saleh J; el-Eissawy S
Egypt J Immunol; 2006; 13(2):41-8. PubMed ID: 18689270
[TBL] [Abstract][Full Text] [Related]
18. Vincristine-cyclophosphamide combination therapy positively affects T-cell subset distribution in systemic lupus erythematosus patients.
Chen J; Ding L; Meng W; Yang J; Yan C; Xie J; Jing L; Li X; Fu Z
Med Sci Monit; 2015 Feb; 21():505-10. PubMed ID: 25683262
[TBL] [Abstract][Full Text] [Related]
19. Imbalance between CD8
Minning S; Xiaofan Y; Anqi X; Bingjie G; Dinglei S; Mingshun Z; Juan X; Xiaohui J; Huijuan W
Lupus; 2019 Sep; 28(10):1214-1223. PubMed ID: 31399013
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory chemokine profiles and their correlations with effector CD4 T cell and regulatory cell subpopulations in cutaneous lupus erythematosus.
Méndez-Flores S; Hernández-Molina G; Azamar-Llamas D; Zúñiga J; Romero-Díaz J; Furuzawa-Carballeda J
Cytokine; 2019 Jul; 119():95-112. PubMed ID: 30903869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
